Head and Neck Squamous Cell Carcinoma — Trials

Head and Neck Squamous Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,589 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 592
Recruiting: 314
Ph III recruiting: 31
Growth YoY: +30.1%
Industry share: 28%
Top sponsor: National Cancer Institute (NCI)
Termination share: 37.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (247)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04766827	Albumin-bound Paclitaxel Combined With Cisplatin Versus Docetaxel Combined With Cisplatin Induced Chemotherapy in Advanced Head and Neck Squamous Tummor	unknown	Phase 4	116	Tianjin Medical University Cancer Institute and HospitalOTHER	1	Feb 23, 2021	clinicaltrials
NCT03196843	Radiotherapy Combine With Raltitrexed Versus Radiotherapy Alone in Older Patients With HNSCC.	unknown	Phase 4	202	The First Affiliated Hospital of Dalian Medical UniversityOTHER